# Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

> **NCT02827734** · — · UNKNOWN · sponsor: **Universitätsmedizin Mannheim** · enrollment: 50 (estimated)

## Conditions studied

- Pulmonary Healthy Controls
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Non-specific Interstitial Pneumonia
- Sarcoidosis
- Granulomatosis With Polyangiitis (Wegener's Disease)

## Interventions

- **DEVICE:** multiple breath washout tests
- **DEVICE:** impulse oscillometry
- **DEVICE:** body plethysmography

## Key facts

- **NCT ID:** NCT02827734
- **Lead sponsor:** Universitätsmedizin Mannheim
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02827734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02827734, "Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02827734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
